Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis
Clinical trial NCT03912259 · COMPLETED
Trial details
- NCT number
- NCT03912259
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-19
- Primary completion
- 2020-02-14
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.